申请人:Hoechst Aktiengesellschaft
公开号:US04734406A1
公开(公告)日:1988-03-29
Compounds of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and Y have the indicated meanings, their physiologically tolerated acid addition salts, and a process for the preparation of these compounds, are described. The compounds inhibit thromboxane synthetase and can thus be used as medicaments.
本发明涉及化合物I的公式##STR1##其中R.sup.1,R.sup.2,R.sup.3和Y具有所示意义,它们的生理耐受性酸加盐以及制备这些化合物的过程。这些化合物抑制血栓素合酶,因此可用作药物。